1. Microbiota-Gut-Brain Communication in the SARS-CoV-2 Infection.
- Author
-
Manosso LM, Arent CO, Borba LA, Ceretta LB, Quevedo J, and Réus GZ
- Subjects
- Dysbiosis, Humans, Inflammation, Mood Disorders, Nervous System Diseases, Brain physiology, COVID-19 physiopathology, Gastrointestinal Microbiome physiology
- Abstract
The coronavirus disease of 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome 2 (SARS-CoV-2). In addition to pneumonia, individuals affected by the disease have neurological symptoms. Indeed, SARS-CoV-2 has a neuroinvasive capacity. It is known that the infection caused by SARS-CoV-2 leads to a cytokine storm. An exacerbated inflammatory state can lead to the blood-brain barrier (BBB) damage as well as to intestinal dysbiosis. These changes, in turn, are associated with microglial activation and reactivity of astrocytes that can promote the degeneration of neurons and be associated with the development of psychiatric disorders and neurodegenerative diseases. Studies also have been shown that SARS-CoV-2 alters the composition and functional activity of the gut microbiota. The microbiota-gut-brain axis provides a bidirectional homeostatic communication pathway. Thus, this review focuses on studies that show the relationship between inflammation and the gut microbiota-brain axis in SARS-CoV-2 infection.
- Published
- 2021
- Full Text
- View/download PDF